News

News Read More

October 5, 2026

Lanterne Dx Completes Merger with Flagship Biosciences, Expanding Biomarker and Digital Pathology Capabilities

• Portfolio Company News

News Read More

September 22, 2026

NIS + Proteos Unite as TrueCourse Biosciences as Demand Surges for Wet-Lab Validation of AI-Designed Drugs

• Portfolio Company News

News Read More

September 8, 2026

Purna Pharmaceuticals Strengthens Leadership Team With Appointment of Industry Veterans

• Portfolio Company News

News Read More

August 27, 2026

Ampersand Capital Partners Recognized Among GrowthCap’s Top Private Equity Firms of 2026

• Ampersand News

News Read More

July 9, 2026

Ampersand Ranks #6 Globally in HEC Paris–Dow Jones Growth Capital Performance Ranking

• Ampersand News

News Read More

July 6, 2026

Ampersand’s Melanie Fan, Partner, Named a Top Women Leader in Growth Investing of 2026 by GrowthCap

• Ampersand News

News Read More

June 30, 2026

Corten Capital and Ampersand Capital Partners Complete Acquisition of Beacon Intelligence to Accelerate Growth in Life Sciences R&D Intelligence

• Ampersand News

News Read More

June 9, 2026

VIVEbiotech Adds Newest in vivo Lentiviral Vector-based Therapeutic Programs

• Portfolio Company News